Advertisement

Topics

Companies Related to "Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma" [Most Relevant Company Matches] - Page: 20 RSS

22:17 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma" found in our extensive corporate database of over 50,000 company records.

Showing "Lenalidomide Rituximab Maintenance Therapy Treating Patients With Cell" Companies 476–500 of 6,100+

Probably Relevant

American Society of Health-System Pharmacists

ASHP Vision Statement for Pharmacy Practice in Hospitals and Health SystemsASHP dedicates itself to achieving a vision for pharmacy practice in hospitals and health systems in which pharmacists:Will significantly enhance patients’ health-related quality of life by exercising leadership in improving both the use of medications by individuals and the overall process of medication use. Will manage ...


AMT B.V

Founded in 1998 on the initiative of researchers from the Academic Medical Center (AMC) in Amsterdam, AMT has become a leader in the field of human gene therapy. A pioneer in the development of gene therapy AMT has used its scientific know-how and expertise to build up a strong research and clinical development program filling an unmet medical need for therapy of severe (orphan) diseases in the fo...

Genea Stem Cells Pty Ltd

Genea Biocells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Biocells Pty Ltd is governed by the same strong ethical principles and corporate governance practices. Genea Biocells is located in Sydney, Australia and has been supplying commercial stem cell solutions for several...


Ocular Surface Center, P.A.

Ocular Surface Foundation (OSF) is a non-profit public medical research foundation (501c3) established in 1999, and carries s single mission of promoting the spread of the knowledge and skills that are important for treating ocular surface diseases. Under the leadership of the President, Billy K. Yeh, M.D., Ph.D., OSF supports research and educational programs that may create a differentiable valu...

CathWorks

CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits for patients with...

Autolus Therapeutics Limited

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognise cancer c...

Semma Therapeutics, Inc.

Semma Therapeutics is pioneering the new treatment paradigm of using cells as medicine. Semma’s new class of regenerative medicine therapies couples its breakthrough stem cell technologies with proprietary delivery systems designed to protect cells from the immune system. Ongoing research at Semma Therapeutics is focused on combining these highly-diff...

Clearside Biomedical, Inc.

Clearside Biomedical is an Atlanta-based, clinical phase ophthalmic pharmaceutical company improving drug performance through tissue-targeted microinjection into distinct compartments of the eye to treat sight-threatening disease. Clearside Biomedical’s proprietary microinjection dosing platform consistently delivers drug to the suprachoroidal space (...

Catheter Connections, Inc.

Headquartered in Salt Lake City, Utah, Catheter Connections, Inc., a University of Utah start-up, develops and commercializes innovative vascular access products designed to protect patients from acquiring infections during periods of intravenous infusion therapy. For more information visit www.catheterconnections.com.

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

Nuvelo

Nuvelo, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular and cancer therapy. Nuvelo's development pipeline includes several acute cardiovascular and oncology programs. The cardiovascular portfolio includes three programs: alfimeprase, a direct acting thr...

BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.

InQ Biosciences Corporation

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company's InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ...

Ortho Biotech Incorporated

Ortho Biotech Inc. is a member of the Johnson & Johnson family of companies. As a company engaged in the business of innovative research, Ortho Biotech is pleased to share with professionals and patients its resources on the subject of anemia associated with HIV therapy.

InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was complet...

Quality Biological, Inc.

Quality Biological, Inc., founded in 1983, is a privately held company located in Gaithersburg, Maryland. Quality Biological provides products and supplies for the molecular biology laboratory (including buffers, and RNA and DNA reagents) and for the cell biology laboratory (including traditional cell culture media, the QBSF® range of serum-free media, and products for stem cell culture and hemat...

Semafore Pharmaceuticals, Inc.

Founded in 2000, Semafore Pharmaceuticals is a clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule signal transduction inhibitors targeting the phosphoinositide-3-kinase (PI3K) pathway for the treatment of cancer and other serious diseases. The PI3K signaling pathway is vital to several biological process...

Speedel

Speedel is a biopharmaceutical company that seeks to create value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, a promising new approach with significant potential for treating cardiovascular diseases. Our lead product candidate SPP100 (Aliskiren), the first-in-class renin inhibitor,...

Cyclacel Limited

Cyclacel Limited (Dundee, UK) uses cell cycle control biology and state-of-the-art rational drug design chemistry to develop novel cancer therapeutics including small molecule CDK inhibitors (CYC200; CYC400), Penetratin®-small molecule complexes (CYC300), Pimetic™ small molecules mimicking natural cancer suppressing genes (CYC100), and intelligent delivery and targeting systems (Penetratin® an...

Texas Heart Institute

The Texas Heart Institute (www.texasheart.org), founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education and improved patient care. Together with its clinical partner, St. ...

Cerbomed GmbH

Cerbomed is an innovative medical device company located in Erlangen, Germany, that focuses on neuromodulation. The company, founded in 2005, focuses on transcutaneous Vagus Nerve Stimulation (t-VNS), which may offer an attractive therapy option for patients with hard-to-treat neurological and psychiatric illnesses.

Oncogene Research Products

Assays, ELISAs, antibodies, growth factors, receptors, ligands peptides, probes, hormones, neurotoxins, and enzymes for the study of angiogenesis, apoptosis, cancer, cell cycle/proliferation, proteases, signal transduction, neuroscience.cell biology relat

Merck and Cardiome Pharma Corp.

In April 2009, Cardiome and Merck announced a collaboration and license agreement for the development and commercialization of vernakalant. The agreement provides Merck, Sharp and Dohme Corp. (formerly known as Merck & Co., Inc.) with exclusive global rights to vernakalant oral formulation for the maintenance of normal heart rhythm in patients with AF, and...

Tissue Genesis, Inc.

An emerging leader in adipose-derived cell therapy and regenerative medicine, Tissue Genesis, Inc. is a high-growth, clinical-stage company based in Honolulu, Hawai‘i. Industry-leading engineers and scientists have developed a proprietary process for Tissue Genesis that may deliver innovative medical solutions for a wide range of existing medical prob...

Biomedical Technologies Incorporated

BTI Cell Growth Factors & Attachment Factors, BTI Immunoassay Kits, BTI Cell Culture Additives & Components, BTI Lipoproteins/Proteins, BTI Antibodies, BTI [I125] Labeled Compounds & Custom [I125] Radioiodinations.


More From BioPortfolio on "Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks